Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Location status: Recruiting
NCT Number: NCT02316379
The goal of this study is to evaluate the usefulness of hyperpolarized (HP) 129Xe (xenon) gas MRI for regional assessment of lung function in a normal population of adults for the purposes of obtaining optimal images through MRI.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 1 / Phase 2
Cincinnati, Ohio, 45229, United States
Location status: Recruiting
Hyperpolarized 129Xe will be produced, by trained staff, using a polarizer housed at Cincinnati Children's Hospital Medical Center. Individual imaging sessions will be done on a single day and will involve administration of (maximum) 1 liter doses for up to four MRI scans. Subject will inhale hyperpolarized xenon gas and hold breath for up to 16 seconds during the MRI scans. In addition to 129 Xe MRI, a series of anatomical conventional proton MR images may also be collected. Follow up will be done one day and 30 days from the MRI date.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
During the scans, subject will inhale hyperpolarized Xenon gas for up to 16 seconds per scan, for up to 4 separate MR scans
Other names: HP 129 Xe
Time frame: Day 1
quantify the measurement agreement between the ventilated volume of healthy lungs predicted via 129 Xe MRI and the ventilated volume of the pleural cavity predicted via proton MRI
Contact information is provided by the study sponsor or research team.
Carrie Stevens, BS
CONTACT
Kelly Thornton, BS
CONTACT
Children's Hospital Medical Center, Cincinnati
Other
Acronym: HpXeMRCal
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02272049
Respiration Disorders, Respiratory Disorders
Cincinnati, Ohio, United States
View Trial DetailsNCT06951633
Respiration Disorders, Respiratory Disorders
Wieliczka, Poland
View Trial DetailsNCT06879639
Arthritis, Cardiovascular Diseases
Vila Nova de Famalicão, Braga District, Portugal
View Trial DetailsNCT03894969
Chronic Disease, DNA Virus Infections
Tallinn, Estonia
View Trial Details